UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028805
Receipt number R000032933
Scientific Title Single arm prospective observational study for severe heart failure patients repeating hospitalization (multicenter study)
Date of disclosure of the study information 2017/08/25
Last modified on 2019/02/25 12:52:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Single arm prospective observational study for severe heart failure patients repeating hospitalization (multicenter study)

Acronym

Single arm prospective study for severe HF patients repeating hospitalization

Scientific Title

Single arm prospective observational study for severe heart failure patients repeating hospitalization (multicenter study)

Scientific Title:Acronym

Single arm prospective study for severe HF patients repeating hospitalization

Region

Japan


Condition

Condition

heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to analyze the characteristics of the change in vital signs before cardiac failure exacerbation obtained from a noninvasive chest attachment type device and a wireless sensor with communication tools.

Basic objectives2

Others

Basic objectives -Others

Safety,Efficacy

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

1) Re-hospitalization caused by heart failure, all deaths during the study period(0.5 year).

Key secondary outcomes

1) An elevation to more than 1000pg/ml of B-type peptide during the study period.
2) The reason why patients dropped out.
3) An expression of adverse events.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients who hospitalized caused by severe heart failure within a year.
2) Patients classified NYHA II or III or IV.
3) Patients who agreed to participate in this research by themselves.
4) Patients who were over 20 years old when they agreed to participate in this research.

Key exclusion criteria

1) Patients who wear pace makers, ICD and CRT(D), or are supposed to wear them.
2) Patients who are valued as inappropriate by a doctor to participate in this research.

Target sample size

160


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koichiro Kinugawa

Organization

University of Toyama

Division name

Second Department of Internal Medicine

Zip code


Address

2630 Sugitani, Toyama

TEL

076-434-7297

Email

kinugawa-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shuji Joho

Organization

University of Toyama

Division name

Second Department of Internal Medicine

Zip code


Address

2630 Sugitani, Toyama

TEL

076-434-7297

Homepage URL


Email

sjoho@med.u-toyama.ac.jp


Sponsor or person

Institute

1) University of Toyama
2) Tokyo Metropolitan Geriatric Hospital

Institute

Department

Personal name



Funding Source

Organization

Secom Science and Technology Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo Metropolitan Geriatric Hospital, SECOM Medical System CO.,LTD.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

富山大学附属病院(富山県)、東京大学医学部附属病院(東京都)、東京都健康長寿医療センター(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 06 Month 29 Day

Date of IRB


Anticipated trial start date

2015 Year 09 Month 30 Day

Last follow-up date

2018 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Data analysis in progress.


Management information

Registered date

2017 Year 08 Month 24 Day

Last modified on

2019 Year 02 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032933


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name